Urinary plasmin activates collecting duct ENaC current in preeclampsia

Hypertension

Volumn 60, Issue 5, 2012, Pages 1346-1351

  Buhl, Kristian B ^a   Friis, Ulla G ^a   Svenningsen, Per ^a   Gulaveerasingam, Ambika ^a   Ovesen, Per ^b   Frederiksen Møller, Britta ^a   Jespersen, Bente ^b   Bistrup, Claus ^c   Jensen, Boye L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

aldosterone; edema; hypertension; kidney; pregnancy; renin

Indexed keywords

ALBUMIN; ALDOSTERONE; ALPHA 2 ANTIPLASMIN; AMILORIDE; CREATININE; EPITHELIAL SODIUM CHANNEL; GELATIN; PLASMIN; PLASMINOGEN; POTASSIUM ION; SERINE PROTEINASE; SODIUM ION;

ALDOSTERONE URINE LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DENATURATION; ENZYMATIC ASSAY; FEMALE; HUMAN; HYPERTENSION; IMMUNOBLOTTING; ION TRANSPORT; KIDNEY COLLECTING TUBULE; PATCH CLAMP; POTASSIUM URINE LEVEL; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN URINE LEVEL; SODIUM RETENTION; SODIUM URINE LEVEL; URINALYSIS; URINARY EXCRETION; WHOLE CELL; ZYMOGRAPHY;

ADULT; ALBUMINURIA; ALDOSTERONE; BLOTTING, WESTERN; CREATININE; CROSS-SECTIONAL STUDIES; EPITHELIAL SODIUM CHANNELS; FEMALE; FIBRINOLYSIN; HUMANS; KIDNEY TUBULES, COLLECTING; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; POTASSIUM; PRE-ECLAMPSIA; PREGNANCY; PROTEOLYSIS; SODIUM;

EID: 84868215236     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.198879     Document Type: Article

References (36)

1. Deschênes G, Wittner M, Stefano A, Jounier S, Doucet A. Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy. J Am Soc Nephrol. 2001;12:598-601.
2. Deschênes G, Guigonis V, Doucet A. Molecular mechanism of edema formation in nephrotic syndrome [in French]. Arch Pediatr. 2004;11:1084-1094.
3. Vallet V, Chraibi A, Gaeggeler HP, Horisberger JD, Rossier BC. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature. 1997;389:607-610.
4. Svenningsen P, Bistrup C, Friis UG, Bertog M, Haerteis S, Krueger B, Stubbe J, Jensen ON, Thiesson HC, Uhrenholt TR, Jespersen B, Jensen BL, Korbmacher C, Skøtt O. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol. 2009;20:299-310.
5. Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med. 1994;124:118-124.
6. Passero CJ, Mueller GM, Rondon-Berrios H, Tofovic SP, Hughey RP, Kleyman TR. Plasmin activates epithelial Na+ channels by cleaving the gamma subunit. J Biol Chem. 2008;283:36586-36591.
7. Svenningsen P, Uhrenholt TR, Palarasah Y, Skjødt K, Jensen BL, Skøtt O. Prostasin-dependent activation of epithelial Na+ channels by low plasmin concentrations. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1733-R1741.
8. Gadau J, Peters H, Kastner C, Kühn H, Nieminen-Kelhä M, Khadzhynov D, Krämer S, Castrop H, Bachmann S, Theilig F. Mechanisms of tubular volume retention in immune-mediated glomerulonephritis. Kidney Int. 2009;75:699-710.
9. Kim SW, Wang W, Nielsen J, Praetorius J, Kwon TH, Knepper MA, Frøkiaer J, Nielsen S. Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats. Am J Physiol Renal Physiol. 2004;286:F922-F935.
10. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, Levy D, Vasan RS. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation. 2005;111:1370-1376.
11. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658.
12. Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing T. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation. 2011;124:940-950.
13. Brown MA, Zammit VC, Whitworth JA. Renin-aldosterone relationships in pregnancy-induced hypertension. Am J Hypertens. 1992;5(6 pt 1):366-371.
14. Brown MA, Wang J, Whitworth JA. The renin-angiotensin-aldosterone system in pre-eclampsia. Clin Exp Hypertens. 1997;19:713-726.
15. Brown MA, Gallery ED, Ross MR, Esber RP. Sodium excretion in normal and hypertensive pregnancy: a prospective study. Am J Obstet Gynecol. 1988;159:297-307.
16. Brown MA, Reiter L, Rodger A, Whitworth JA. Impaired renin stimulation in pre-eclampsia. Clin Sci (Lond). 1994;86:575-581.
17. Vassalli P, Morris RH, Mccluskey RT. The pathogenic role of fibrin deposition in the glomerular lesions of toxemia of pregnancy. J Exp Med. 1963;118:467-478.
18. Chen HF, Nakabayashi M, Satoh K, Sakamoto S. Urinary fibrinolysis in toxemia of pregnancy. Acta Obstet Gynecol Scand. 1980;59:499-504.
19. Chen HF, Nakabayashi M, Satoh K, Sakamoto S. Studies on the purification and characterization of human urinary plasminogen and plasmin. Thromb Haemost. 1980;42:1536-1547.
20. Schild L, Canessa CM, Shimkets RA, Gautschi I, Lifton RP, Rossier BC. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci USA. 1995;92:5699-5703.
21. Pedersen EB, Christensen NJ, Christensen P, Johannesen P, Kornerup HJ, Kristensen S, Lauritsen JG, Leyssac PP, Rasmussen A, Wohlert M. Preeclampsia-a state of prostaglandin deficiency? Urinary prostaglandin excretion, the renin-aldosterone system, and circulating catecholamines in preeclampsia. Hypertension. 1983;5:105-111.
22. August P, Lenz T, Ales KL, Druzin ML, Edersheim TG, Hutson JM, Müller FB, Laragh JH, Sealey JE. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol. 1990;163(5 pt 1):1612-1621.
23. Levario-Carrillo M, Avitia M, Tufiño-Olivares E, Trevizo E, Corral-Terrazas M, Reza-López S. Body composition of patients with hypertensive complications during pregnancy. Hypertens Pregnancy. 2006;25: 259-269.
24. Lambiotte-Escoffier C, Moore DB, Taylor HC Jr. The volume of distribution of inulin, antipyrine, and radiosodium during normal and toxemic pregnancy and during the puerperium. Am J Obstet Gynecol. 1953;66:18-26.
25. Brown MA. Sodium and plasma volume regulation in normal and hypertensive pregnancy: a review of physiology and clinical implications. Clin and Exper-Hyper in Pregnancy. 1988;B7:265-282.
26. Brown MA, Zammit VC, Adsett D. Stimulation of active renin release in normal and hypertensive pregnancy. Clin Sci. 1990;79:505-511.
27. Churchill D, Beevers GD, Meher S, Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev. 2007;CD004451.
28. Al-Ali NA, El-Sandabesee D, Steel SA, Roland JM. Conn's syndrome in pregnancy successfully treated with amiloride. J Obstet Gynaecol. 2007;27:730-731.
29. Almeida OD Jr, Spinnato JA. Maternal Bartter's syndrome and pregnancy. Am J Obstet Gynecol. 1989;160(5 pt 1):1225-1226.
30. Deruelle P, Dufour P, Magnenant E, Courouble N, Puech F. Maternal Bartter's syndrome in pregnancy treated by amiloride. Eur J Obstet Gynecol Reprod Biol. 2004;115:106-107.
31. Cope I, Mitchell P. Plasmin and plasminogen levels in pregnancy. Aust N Z J Obstet Gynaecol. 1965;5:152-155.
32. Andronicos NM, Chen EI, Baik N, Bai H, Parmer CM, Kiosses WB, Kamps MP, Yates JR 3rd, Parmer RJ, Miles LA. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood. 2010;115:1319-1330.
33. Chen KW, Bai H, Kiosses WB, Krajewski S, Miles LA, Parmer RJ. Colocalization of the novel plasminogen receptor, Plg-RKT, with the epithelial sodium channel (ENaC). FASEB J. 2010;24 (Meeting Abstract Supplement):786.22.
34. Wagner SN, Atkinson MJ, Wagner C, Höfler H, Schmitt M, Wilhelm O. Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem Cell Biol. 1996;105:53-60.
35. Toldi G, Bíró E, Szalay B, Stenczer B, Molvarec A, Rigó J, Vásárhelyi B, Bekõ G. Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia. Clin Chem Lab Med. 2011;49:1873-1876.
36. Bruns JB, Carattino MD, Sheng S, Maarouf AB, Weisz OA, Pilewski JM, Hughey RP, Kleyman TR. Epithelial Na+ channels are fully activated by furin-and prostasin-dependent release of an inhibitory peptide from the gamma-subunit. J Biol Chem. 2007;282:6153-6160.